We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





AACC Middle East to Be Held in Abu Dhabi

By LabMedica International staff writers
Posted on 01 Aug 2017
AACC, in partnership with Al Borg Medical Laboratories, will launch a new laboratory medicine conference and expedition next spring – AACC Middle East in Abu Dhabi, United Arab Emirates (UAE) from March 22-24, 2018. More...
The event will offer opportunities to connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine.

AACC brings together more than 50,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science.

AACC Middle East will feature the latest breakthroughs in every area of clinical testing, including mobile health, molecular diagnostics, mass spectrometry, next generation sequencing, point of care, and automation. The scientific program will also feature experts from the U.S. and the Middle East, sharing knowledge and innovation. Attendees will be able to meet and network with experts in the field, and engage with their peers during the scientific program highlighting recent advances in laboratory medicine.

“Healthcare is increasingly global and interconnected,” said AACC CEO Janet B. Kreizman. “The AACC leadership is excited to bring forward this new opportunity for laboratory experts from a range of healthcare settings to learn about the latest innovations in clinical testing and engage with like-minded professionals from the Middle East and nearby regions. We expect that all the major players in the IVD industry will want to be a part of this groundbreaking event.”


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.